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        Free radicals and their reactive metabolites 
(reactive oxygen species [ROS]) exist in neu-
ronal cells and tissues at low but measurable 
concentrations (  1  ). These tolerable equilib-
rium concentrations are the result of a tightly 
controlled balance between the rates of pro-
duction and clearance, the latter being medi-
ated by a team of antioxidants including enzymes 
and nonenzymatic compounds such as the tri-
peptide glutathione. 
  Cells or tissues are in a stable oxidative 
state if the rates of ROS production and scav-
enging capacity remain within a homeostatic 
range. However, if this balance is disturbed, 
either by an increase in ROS concentrations 
or a decrease in antioxidant activities, the re-
sponse may not be suffi   cient to keep the sys-
tem at a level compatible with survival. In 
such cases, oxidants can modify cellular tar-
gets, leading to cell dysfunction or death (  2  ). 
Indeed, oxidative stress has been implicated in 
virtually all of the major acute and chronic 
neurodegenerative diseases (  3  ). 
  In many cells, including cortical neurons, 
the expression of genes with antioxidative ac-
tivity is precisely controlled by a synergistic 
network of redox-sensing signaling cascades 
(  4, 5  ). Specifi  cally, aberrant levels of oxidants can 
trigger the transcriptional induction of antioxi-
dative enzymes and other adaptive pathways (  5  ). 
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  Oxidative stress is pathogenic in neurological diseases, including stroke. The identity of 
oxidative stress  –  inducible transcription factors and their role in propagating the death 
cascade are not well known. In an in vitro model of oxidative stress, the expression of the 
bZip transcription factor activating transcription factor 4 (ATF4) was induced by glutathi-
one depletion and localized to the promoter of a putative death gene in neurons. Germline 
deletion of ATF4 resulted in a profound reduction in oxidative stress  –  induced gene expres-
sion and resistance to oxidative death. In neurons, ATF4 modulates an early, upstream event 
in the death pathway, as resistance to oxidative death by ATF4 deletion was associated 
with decreased consumption of the antioxidant glutathione. Forced expression of ATF4 was 
suffi  cient to promote cell death and loss of glutathione. In ATF4      /      neurons, restoration of 
ATF4 protein expression reinstated sensitivity to oxidative death. In addition, ATF4      /      mice 
experienced signifi  cantly smaller infarcts and improved behavioral recovery as compared 
with wild-type mice subjected to the same reductions in blood fl  ow in a rodent model of 
ischemic stroke. Collectively, these fi  ndings establish ATF4 as a redox-regulated, prodeath 
transcriptional activator in the nervous system that propagates death responses to oxida-
tive stress in vitro and to stroke in vivo. 1228 ATF4 IS A PRODEATH PROTEIN IN NEURONS | Lange et al.
dative stress alone was suffi   cient to induce ATF4 protein 
levels (  Fig. 1 C  ). 
  Cortical neurons from ATF4      /      brains are resistant 
to oxidative stress  –  induced cell death 
  To verify that the protection by arginase and thapsigargin re-
quires ATF4, we cultured cortical neurons from brains of 
embryonic ATF4      /      mice (E15.5). Immunohistochemical 
analysis (  Fig. 2 A  ) using an antibody to microtubule-associ-
ated protein 2 (MAP2; which stains neural dendrites) showed 
that basal viability and morphology of cell bodies and den-
drites did not display any diff  erences between ATF4  +/+   and 
ATF4      /      neurons.   We found that ATF4 mRNA was in-
duced in ATF4  +/+   neurons after oxidative stress and con-
fi  rmed its absence in ATF4      /      neurons (  Fig. 2 B  ). We then 
examined susceptibility to oxidative stress induced by the 
glutamate analogue homocysteate (HCA) in ATF4  +/+   and 
ATF4      /      cortical neurons (  Fig. 2, C and D  ). Contrary to our 
hypothesis, we found that ATF4      /      neurons were signifi  -
cantly protected from oxidative stress  –  induced death. ATF4      /      
neurons demonstrated enhanced resistance, as monitored by 
MTT reduction (  Fig. 2 C  ) and live/dead staining (  Fig. 2 D  ). 
Moreover, in ATF4  +/+   neurons, ATF4 induction by treat-
ment with HCA was a result of induction at the translational 
level (  Fig. 2 E  ). We confi  rmed the nuclear accumulation of 
ATF4 in ATF4  +/+   neurons exposed to oxidative stress (  Fig. 
2 F  ). Higher nuclear ATF4 activity after oxidative stress was 
demonstrated by showing higher promoter activity of an 
ATF4 target gene, tribbles homologue 3 (TRB3), that has 
been recently associated with cell death. TRB3 mRNA is 
induced upon HCA treatment in an ATF4-dependent man-
ner (  Fig. 2 G  ). To characterize ATF4 binding on the pro-
moter of TRB3, we generated a 2-kb fragment of the mouse 
TRB3 promoter (  Fig. 2 H  ). This fragment contains a 33-bp 
element whose human analogue has been characterized as a 
DNA binding region of ATF4. Transfection of both ATF4  +/+   
and ATF4      /      neurons with the TRB3WT promoter con-
struct, along with a mutant version lacking the binding ele-
ment, revealed that this element plays an important but not 
exclusive role in the induction of the TRB3 promoter after 
oxidative stress. In the absence of ATF4, the TRB3 promoter 
activity was not induced in response to oxidative stress. 
  Microarray analysis reveals that ATF4 regulates a subset 
of genes that are induced in response to oxidative stress 
  In fi  broblasts, previous studies (  11  ) have established ATF4 as 
an important prosurvival transcription factor in the context of 
oxidative stress. Microarray analysis in that study (  11  ) showed 
that several ATF4-regulated genes in fi  broblasts are involved 
in amino acid import, glutathione biosynthesis, antioxidant 
defense, and DNA repair. In contrast, in neurons, ATF4 has 
classically been thought to act mainly as a transcriptional re-
pressor. In this context, ATF4 has been hypothesized to nega-
tively infl  uence survival by repressing expression of genes 
that are otherwise activated by prosurvival transcriptional ac-
tivators such as cAMP response element binding protein. 
The cellular response to oxidative stress is tightly controlled 
by a family of stress-responsive transcription factors (  2, 6  ). 
Among these transcription factors, the activating transcrip-
tion factor 4 (ATF4)/cAMP response element binding protein 
2 may be a key player (  7  –  9  ). ATF4 is expressed constitutively 
only at low concentrations but becomes rapidly induced under 
particular cell-stress conditions (  10  ). ATF4 binds to the pro-
moter regions of an array of diff  erent target genes, includ-
ing many involved in amino acid metabolism and redox 
control (  11  ). In fi  broblasts, ATF4 coordinates the response to 
amino acid depletion, oxidative stress, and endoplasmic retic-
ulum stress, and helps to balance redox homeostasis. Indeed, 
ATF4-defi  cient fi  broblasts have been shown to be prone to 
death after a host of stresses, including oxidative stress and 
amino acid deprivation (  11  ). 
  Interestingly, amino acid deprivation has been previously 
reported to be neuroprotective in an in vitro model of oxida-
tive stress  –  induced cell death (  12  ). This model employs im-
mature cortical neurons and takes advantage of the absence of 
glutamate receptors at this stage of development to avoid ex-
citotoxicity. Instead, addition of glutamate analogues com-
petitively inhibits uptake of cyst(e)ine, the rate-limiting 
precursor for the tripeptide glutathione. The resulting de-
cline in glutathione concentration is a primary event that 
leads to neuronal cell death from oxidative stress (  13  –  15  ), a 
process that displays many features of apoptosis (  14  –  16  ). This 
glutathione depletion model facilitates the separation of bio-
chemical events that mediate death from those that are a con-
sequence of death, and it is highly relevant to pathological 
conditions because an increase in cellular ROS production is 
often observed in apoptotic processes triggered by diverse 
stimuli associated with disease states. In this work, we defi  ne 
a novel prodeath role for ATF4 in neurons in vitro in re-
sponse to oxidative stress and in vivo in response to stroke, a 
condition linked to oxidative stress. 
    RESULTS   
  Amino acid depletion and thapsigargin treatment 
induce ATF4 and protect embryonic cortical neurons 
from oxidative stress  –  induced cell death 
  Amino acid depletion via the arginine-degrading enzyme 
arginase is a well-characterized strategy for protecting neu-
rons from oxidative stress  –  induced cell death (  12, 17  ). 
Studies in nonneural cells have shown that amino acid de-
privation activates cell-survival pathways by activating the 
bZip transcription factor ATF4 (  11  ). We initiated our stud-
ies with the hypothesis that arginase is a multipotent inhibi-
tor of apoptotic neuronal cell death by activating ATF4 and 
its downstream gene targets. Because endoplasmic reticu-
lum stress by thapsigargin is also associated with increased 
ATF4 expression (  18  ), we examined the corollary hypoth-
esis that this agent could initiate tolerance to oxidative stress 
in primary cortical neurons. As predicted, arginase and 
thapsigargin led to nearly complete protection from neuro-
nal cell death (  Fig. 1, A and B  ) and to accumulation of 
ATF4 protein (  Fig. 1 C  ).   Interestingly, we found that oxi-JEM VOL. 205, May 12, 2008 
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To begin to examine whether ATF4 functions primarily as a 
repressor or activator in neurons and to determine the extent 
to which these ATF4-regulated genes function similarly in 
fi  broblasts and neurons, we performed a global analysis of gene 
expression using microarrays in ATF4  +/+   and ATF4      /      
neurons (  Fig. 3 A  ).   More specifi  cally, we assessed (a) the 
physiological genomic eff  ect of ATF4 knockout (comparing 
ATF4      /      with ATF4  +/+   neurons), and (b) the eff  ect of ATF4 
knockout on the response to oxidative stress (comparing 
ATF4      /      with ATF4  +/+   neurons after HCA treatment;   Fig. 3 
B   and   Table I  ).   At the chosen statistical threshold (5% false 
discovery rate), 136 probes were down-regulated in ATF4      /      
versus ATF4  +/+   neurons, compared with 53 that were up-
regulated, suggesting a role for ATF4 as a transcriptional acti-
vator. Functional gene ontology categories overrepresented in 
this list include mitochondrion, oxidoreductase activity, and 
amino acid metabolism. Several of the down-regulated genes 
have been shown to be positively regulated by ATF4, includ-
ing the prodeath gene TRB3. Comparison of ATF4      /      versus 
ATF4  +/+   neurons after oxidative stress with HCA treatment 
suggested a fundamental role of ATF4 in modulating oxida-
tive stress  –  induced gene expression. In fact, 119 probes are 
dysregulated in response to oxidative stress in ATF4  +/+   neu-
rons, whereas only 3 change in ATF4      /      neurons. Collec-
tively, these fi  ndings suggest that ATF4 is a major upstream 
regulator of oxidative stress  –  induced changes in gene ex-
pression. Additionally, for most genes in embryonic cortical 
neurons, ATF4 functions as an activator and not a repressor. 
  Gene expression array data were obtained from ATF4      /      
fi  broblasts that display a higher susceptibility to oxidative stress 
(  11  ). A signifi  cant overlap could be observed between the array 
data from ATF4      /      fi  broblasts and neurons (Table S1, available 
at http://www.jem.org/cgi/content/full/jem.20071460/DC1), 
indicating that ATF4 regulates at least a major part of target 
genes in a cell type  –  independent manner. These similarities do 
not explain the observation that ATF4 is prosurvival in fi  bro-
blasts and prodeath in neurons, but they demonstrate the re-
liability in our analysis. In contrast, a subset of genes, including 
the prodeath gene TRB3, were ATF4-regulated in neurons 
but not in fi  broblasts. Collectively, these fi  ndings provide some 
understanding of the tissue-specifi  c gene regulation mediated 
by ATF4 that could account for the divergent phenotypes in 
dividing fi  broblasts versus postmitotic neurons. 
Dunn  ’  s multiple comparisons test. (B) Live/dead assay of cortical neuronal 
cultures (2 d in vitro). Live cells were detected by uptake and trapping of 
calcein-AM (green fl  uorescence). Dead cells failed to trap calcein but were 
freely permeable to the highly charged DNA intercalating dye ethidium 
homodimer (red fl  uorescence). Bar, 50   μ  m. (C) Treatment with 10 mM HCA 
(shown as H) and 1   μ  g/ml arginase (shown as A) or 1   μ  M thapsigargin 
(shown as T), alone or in combination with HCA, increases the expression of 
ATF4 in cultured cortical neurons as compared with vehicle-treated control 
(shown as C). Cells were harvested at the indicated time points, and nuclear 
extracts were separated using gel electrophoresis and immunodetected 
using an antibody against ATF4. YY1 was monitored as a loading control. 
The immunoblot is a representative example of three experiments.    
 
    Figure 1.         Amino acid depletion and thapsigargin treatment induce 
ATF4 and protect embryonic cortical neurons from oxidative stress  –
  induced cell death.   (A) Cortical neuronal cultures (1 d in vitro) were treated 
with a vehicle control (shown as C), 10 mM of the glutamate analogue HCA, 
1   μ  g/ml arginase, 1   μ  M thapsigargin, 1   μ  g/ml arginase and 10 mM HCA, or 
10 mM HCA and 1   μ  M thapsigargin. 24 h later, cell viability was determined 
using the MTT assay. The graph depicts mean (compared with control)   ±   SD 
calculated from three separate experiments for each group (  n   = 25). *, P   <   
0.05 from HCA-treated cultures by the Kruskal-Wallis test followed by 1230 ATF4 IS A PRODEATH PROTEIN IN NEURONS | Lange et al.
    Figure 2.         Cortical neurons from ATF4      /      brains are resistant to oxidative stress  –  induced cell death.   (A) Immunocytochemistry of cultured ATF4  +/+   and 
ATF4     /     cortical neurons. Cells were stained with an antibody against MAP2 (which stains neural dendrites; red) and counterstained with Hoechst (blue). Bar, 50   μ  m. 
(B) Real-time PCR of ATF4 mRNA expression in ATF4  +/+   and  ATF4    /     neurons in response to treatment with 10 mM HCA. The value obtained from the ATF4  +/+   
control was arbitrarily defi  ned as 1. Mean   ±   SD was calculated from three separate experiments. Each data point was performed in duplicate. (C) Cortical neuro-
nal cultures (1 d in vitro) prepared from brains from ATF4  +/+   and  ATF4    /     embryos were treated with a vehicle control (shown as C) or 10 mM HCA. 24 h later, cell 
viability was determined using the MTT assay. The graph depicts mean (compared with control)   ±   SD calculated from data from fi  ve separate experiments (  n   =  27 
ATF4  +/+   and 73 ATF4     /    ). *, P   <   0.05 from ATF4  +/+   untreated cultures by the Kruskal-Wallis test followed by Dunn  ’  s multiple comparisons test. The difference be-
tween treated and untreated ATF4     /     neurons was not signifi  cant (n.s.). (D) Representative live/dead assay displaying untreated and HCA-treated ATF4  +/+   and 
ATF4     /     neurons. Bar, 50   μ  m. (E) ATF4  +/+   neurons were transfected with a reporter plasmid (pGL3 backbone) containing the mouse ATF4 5    UTR and AUG fused to 
luciferase. Cortical neurons were cotransfected with a plasmid expressing Renilla to allow normalization for transfection effi  ciency. 24 h after transfection, neu-
rons were treated with vehicle control (shown as C) or 10 mM HCA. Cells were harvested in luciferase assay buffer 12 h after the onset of treatment. Values were JEM VOL. 205, May 12, 2008 
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  ATF4 has a negative impact on neuronal glutathione 
metabolism 
  The loss of glutathione is central to the in vitro model of 
oxidative stress used in this study. This model has been suc-
cessfully used to describe signaling pathways that prevent 
cell death downstream of glutathione depletion. However, 
in fi  broblasts, ATF4 has been described as a positive regula-
tor of glutathione metabolism ( 11  ). Therefore, we performed 
glutathione measurements to determine whether ATF4 per-
mits cell death in response to HCA by direct infl  uence of the 
neuronal glutathione metabolism or by acting downstream 
of glutathione depletion. In untreated neurons, glutathione 
concentrations in ATF4  +/+   and ATF4      /      neurons did not 
diff  er (  Fig. 6 A  ).   As anticipated, HCA treatment caused a 
progressive loss of glutathione in ATF4  +/+   neurons. How-
ever, ATF4      /      neurons displayed a markedly slower decline 
in glutathione concentration. To rule out the possibility that 
an increased rate of glutathione synthesis is responsible for 
decreased sensitivity to cystine deprivation  –  induced gluta-
thione depletion (  20  ), we used buthionine sulfoximine (BSO) 
to directly inhibit the rate-limiting enzyme of glutathione 
synthesis,     -glutamylcysteine synthetase (    -GCS;   Fig. 6 B  ). 
BSO resulted in cell death in ATF4  +/+   neurons, whereas 
ATF4      /      neurons were essentially resistant (  Fig. 6, C and D  ). 
As expected from these results,     -GCS expression did not 
diff  er between ATF4  +/+   and ATF4      /      neurons at the pro-
tein level and did not appear in the gene array (  Fig. 6 E  ). 
Similar to HCA, BSO treatment led to a decline in the con-
centration of glutathione in ATF4  +/+   neurons, whereas 
ATF4      /      neurons displayed a distinctly slower reduction of 
glutathione (  Fig. 6 F  ). These fi  ndings are consistent with the 
notion that the diff  erences in reduction of glutathione after 
HCA or BSO is not attributable to changes in synthesis. To 
determine whether ATF4 directly regulates the neuronal 
glutathione content, we measured glutathione in neurons 
with forced expression of ATF4WT, ATF4    RK, and GFP 
(  Fig. 6 G  ). Consistent with the fi  nding that forced expression 
of ATF4WT can reduce neuronal viability, we found that 
this viability reduction correlates with a reduction in the 
neuronal glutathione content. Because cell death attribut-
able to glutathione depletion can be completely blocked by 
a whole host of classical antioxidants, we combined forced 
expression of ATF4WT with butylated hydroxyanisol 
(BHA) treatment (  Fig. 6, H and I  ). BHA is a well characterized 
  Overexpression of ATF4 is suffi  cient to restore sensitivity 
to glutathione depletion  –  induced cell death and is capable 
of inducing cell death by itself 
  Because we used germline knockout animals ( 19  ) in this study, 
we could not exclude the possibility that the decreased sus-
ceptibility to oxidative stress was a consequence of a compen-
satory eff  ect distantly related to ATF4 defi  ciency. To address 
this question, we used adenoviral overexpression of a mouse 
ATF4WT construct. As a control, we used a dominant-
negative ATF4 construct harboring a mutation in its DNA 
binding domain (  292  RYRQKKR  298   to   292  GYLEAAA  298  ). To 
confi  rm the diff  erent DNA binding properties of these con-
structs, we analyzed the 33-bp binding region of the TRB3 
promoter by gel-shift (  Fig. 4 A  ) and chromatin immuno-
precipitation studies (  Fig. 4 B  ).   In fact, only nuclear extracts 
from cells overexpressing ATF4WT in combination with 
WT oligonucleotide formed a band specifi  c for ATF4. Con-
sistently, only TRB3 promoter chromatin from cells over-
expressing ATF4WT could be PCR amplifi  ed using primers 
fl  anking the ATF4 binding site. Cotransfection of WT and 
mutant ATF4 constructs with reporter constructs containing 
the WT and the mutant binding site confi  rmed the activating 
eff  ect ATF4 has on transcription (  Fig. 4 C  ). 
  To determine whether forced expression of ATF4 in 
ATF4      /      neuronal cultures can restore sensitivity to oxidative 
stress and/or has an eff  ect itself, we overexpressed both constructs 
along with a GFP control in both ATF4  +/+   and ATF4      /      cor-
tical neuronal cultures, followed by treatment with HCA (  Fig. 
5  ).   We confi  rmed the effi   cient expression of both ATF4 con-
structs in cortical neurons by immunohistochemistry (  Fig. 5 A  ) 
and Western blotting (  Fig. 5 B  ). Specifi  cally,     50% of neurons 
and a small number of glia are infected with the adenoviruses. 
Infection with ATF4    RK was able to protect ATF4  +/+   corti-
cal neuronal cultures from HCA-induced toxicity (  Fig. 5, C 
and D  ), whereas infection with ATF4WT was capable of ren-
dering ATF4      /      neurons sensitive to HCA (  Fig. 5, E and F  ). 
Moreover, infection with ATF4WT itself signifi  cantly reduced 
the viability in both WT and ATF4      /      neurons. Combination 
of forced expression of ATF4WT and treatment with HCA re-
sulted in a higher loss of viability than infection with ATF4WT 
alone, suggesting that at least one more pathway in addition to 
ATF4 is involved in HCA toxicity. Collectively, these results 
are consistent with the notion that ATF4 indeed plays a key 
role in oxidative stress  –  mediated cell death. 
calculated from three separate experiments and are given as the ratio of luciferase and Renilla activities (mean   ±   SD;   n   = 3). The value for treatment with vehicle 
control was arbitrarily defi  ned as 1. (F) Oxidative stress results in nuclear accumulation of ATF4 in cultured cortical neurons. 60   μ  g of nuclear extracts from corti-
cal neurons treated with 10 mM HCA or vehicle control (shown as C) were separated using gel electrophoresis and immunodetected using an antibody against 
ATF4. YY1 was monitored as a loading control. (G) Real-time PCR of TRB3 mRNA expression in ATF4  +/+   and  ATF4    /     neurons in response to treatment with 10 
mM HCA. The value obtained from the ATF4  +/+   control was arbitrarily defi  ned as 1. Mean   ±   SD was calculated from three separate experiments. Each data point 
was performed in duplicate. (H) ATF4  +/+   and  ATF4    /     neurons were transfected with a luciferase reporter plasmid (pGL3 backbone) containing a 2-kb fragment of 
the mouse TRB3 promoter (TRB3WT), with a mutant version of this promoter lacking the 33-bp ATF4 binding site (TRB3    33bp) or with the empty vector (pGL3 
basic). Cortical neurons were cotransfected with a plasmid expressing Renilla to allow normalization for transfection effi  ciency. 24 h after transfection, neurons 
were treated with vehicle control (shown as C) or 10 mM HCA. Cells were harvested in luciferase assay buffer 12 h after the onset of treatment. Values are given 
as the ratio of luciferase and Renilla activities (mean   ±   SD) and were calculated from three separate experiments. Each data point was performed in duplicate. 
Values are given as the ratio of luciferase and Renilla activities (mean   ±   SD;   n   = 3). The value for empty pGL3 was arbitrarily defi  ned as 1.    
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ing the redox-sensitive probe 2    ,7    -dichlorofluorescin 
(DCF; Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20071460/DC1). Indeed, ATF4      /      neurons dis-
played lower levels of ROS in response to HCA treatment 
than ATF4  +/+   neurons. These fi  ndings are consistent with 
antioxidant known to block HCA-induced cell death in 
cortical neurons (  6  ). In fact, in neurons overexpressing 
ATF4WT, BHA signifi  cantly increased neuronal viability 
and protected against the additional toxic eff  ect of HCA 
treatment. Finally, we measured production of ROS by us-
    Figure 3.         Gene expression array analysis of ATF4  +/+   and ATF4      /      neurons before and after treatment with HCA.   (A) Heatmap with cluster 
dendrogram of the differentially expressed genes (log2 fold change vs. control) at a false discovery rate of 5%. Unsupervised clustering groups samples 
by genotype and by treatment. Genes are in rows and samples are in columns. Column color coding is as follows: red, ATF4     /     versus  ATF4 +/+   untreated 
neurons; blue, HCA-treated ATF4     /     versus untreated ATF4     /     neurons; and green, HCA-treated ATF4  +/+   versus untreated ATF4  +/+   neurons. (B) The num-
ber of genes that are up- (red) and down-regulated (green). Shown are three different contrasts: ATF4     /     versus  ATF4 +/+   untreated neurons, HCA-treated 
ATF4  +/+   versus untreated ATF4  +/+   neurons, and HCA-treated ATF4     /     versus untreated ATF4     /     neurons. The complete list of differentially expressed 
genes is available in Table S3 (available at http://www.jem.org/cgi/content/full/jem.20071460/DC1). ANOVA FDR, analysis of variance false discovery 
rate; C, control.     JEM VOL. 205, May 12, 2008 
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been associated with stroke pathology and repletion of anti-
oxidants has reduced neuronal damage (  22  ). Therefore, we 
hypothesized that ATF4 defi  ciency might positively infl  u-
ence the antioxidant status in the adult brain and thereby im-
prove the outcome after ischemia-reperfusion injury. To test 
the hypothesis that ATF4 germline knockout animals have 
less neuronal loss after stroke, we used a transient middle ce-
rebral artery occlusion (MCAo) model for ischemia-reperfu-
sion injury, as previously described (  23  ). 
the notion that ATF4 positively infl  uences ROS levels and 
leads to a higher consumption of glutathione independent of 
its synthesis. 
  ATF4      /      animals are less susceptible to ischemic brain damage 
  Oxidative stress is an established mediator of neuronal loss in 
cerebral ischemia (  21  ). It is generally accepted that glutathi-
one acts as a major endogenous cerebral antioxidant in the 
adult brain. In fact, depletion of intracellular antioxidants has 
    Table I.        Differentially expressed genes in ATF4  -/-   neurons versus ATF4  +/+   neurons before and after HCA treatment 
From each of the three contrasts, the top 30 genes with the highest fold change were selected. Ratios are log2 transformed. Up-regulated genes (fold change   >   0.2) are 
highlighted in red, and down-regulated genes (fold change   <       0.2) are highlighted in green.1234 ATF4 IS A PRODEATH PROTEIN IN NEURONS | Lange et al.
cerebral blood vessels of the circle of Willis (  Fig. 7 A  , middle) 
(  23  ). Besides a higher degree of tortuosity in the MCA, no 
major abnormalities were detected in the brains obtained from 
ATF4      /      mice. Finally, using immunofl  uorescent staining for 
the endothelial-specifi  c marker CD31/PECAM, we did not 
observe signifi  cant diff  erences in the density or morphology 
of the microvessels (  Fig. 7 A  , bottom). In addition, important 
  First, we performed morphological studies to rule out that 
germline ATF4 defi  ciency causes a fundamental abnormality 
in the adult brain that would bias stroke outcome (  19, 24  –  26  ). 
Examining sagittal sections of brains from ATF4  +/+   and 
ATF4      /     animals (  Fig. 7 A  , top), we did not detect any sig-
nifi  cant structural diff  erences in the cerebellum, hippocam-
pus, or cortex.   We then assessed the morphology of major 
    Figure 4.         ATF4 binds to a 33-bp binding element within the TRB3 promoter.   (A) EMSA performed with 10   μ  g of dialyzed nuclear extracts 
from HT22 cells transfected with ATF4WT, mutant ATF4 (ATF4    RK), or GFP, respectively. Extracts were incubated with a radioactively labeled WT 
oligonucleotide containing the TRB3 promoter binding site or with a mutant oligonucleotide. Binding of ATF4WT to the TRB3WT promoter binding 
site was confi  rmed by supershift analysis (arrow) performed with an antibody (Ab) directed against ATF4. (B) Overexpressed ATF4WT protein occupies 
its putative binding site within the TRB3 promoter in HT22 cells, as shown by chromatin immunoprecipitation assay. HT22 cells were transfected with 
ATF4WT, mutant ATF4 (ATF4    RK), or GFP. An anti-myc antibody was used to precipitate the proteins in nuclear extracts of cross-linked HT22 cells. 
Coprecipitated DNA fragments were detected using PCR with a set of primers specifi  c for the ATF4 binding site in the TRB3 promoter, yielding a 
190-bp product. A representative example of three experiments is shown. (C) HT22 cells were transfected with the expression plasmids for ATF4WT, 
mutant ATF4 (ATF4    RK), or GFP. The cells were cotransfected with either a luciferase reporter vector containing the 33-bp ATF4WT binding site (33 bp 
WT), a reporter vector containing a mutant form of this binding site (33 bp MUT), or empty vector (pGL3 basic). In parallel, the transfection mix con-
tained a plasmid expressing Renilla to allow normalization for transfection effi  ciency. The value for empty pGL3 cotransfected with GFP was arbi-
trarily defi  ned as 1. Shown are ratios of luciferase and Renilla activities (mean   ±   SD for three independent experiments; each data point was 
performed in duplicate).     JEM VOL. 205, May 12, 2008 
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  The procedure used to occlude the MCA (occlusion time = 
45 min) led to reproducible infarcts in WT animals involving 
both the cerebral cortex and the striatum, with sparing of 
physiological parameters did not diff  er between ATF4  +/+   and 
ATF4      /      animals (Fig. S2 and Table S2, available at http://
www.jem.org/cgi/content/full/jem.20071460/DC1). 
    Figure 5.         Overexpression of ATF4WT restores sensitivity to oxidative stress and reduces neuronal viability itself.   (A) Representative immuno-
cytochemistry of ATF4  +/+   and  ATF4    /     cortical neurons infected with the adenoviral constructs ATF4WT and ATF4    RK. Neurons were stained with anti-
bodies against myc (green) and MAP2 (red), and were counterstained with Hoechst dye (blue). Bar, 50   μ  m. (B) Whole-cell extracts obtained from both 
ATF4  +/+   and ATF4     /     neurons infected with GFP, ATF4WT, and ATF4    RK were separated using gel electrophoresis and immunodetected using an antibody 
directed against the myc tag. Total eIF2     was monitored as a loading control. (C) ATF4  +/+   cortical neurons were infected with GFP, ATF4WT, and ATF4   RK 
adenoviruses at an MOI of 100. 24 h after infection, neurons were treated with vehicle control (shown as C) or 10 mM HCA. 24 h later, cell viability was 
determined using the MTT assay. The graph depicts mean (compared with control)   ±   SD calculated from four separate experiments for each group (  n   = 
45). P   <   0.05 by the Kruskal-Wallis test followed by Dunn  ’  s multiple comparisons test from untreated ATF4WT-overexpressing neurons (*) and from HCA-
treated neurons overexpressing GFP (  §  ). (D) Live/dead assay. Bar, 50   μ  m. (E) ATF4     /     cortical neurons were infected with GFP, ATF4WT, and ATF4   RK  ad-
enoviruses at an MOI of 100. 24 h after infection, neurons were treated with vehicle control (shown as C) or 10 mM HCA. 24 h later, cell viability was 
determined using the MTT assay. The graph depicts mean (compared with control)   ±   SD calculated from four separate experiments for each group (  n   = 
28). P   <   0.05 by the Kruskal-Wallis test followed by Dunn  ’  s multiple comparisons test from untreated ATF4WT-overexpressing neurons (*) and from HCA-
treated neurons overexpressing GFP (  §  ). (F) Live/dead assay. Bar, 50   μ  m.     1236 ATF4 IS A PRODEATH PROTEIN IN NEURONS | Lange et al.
    Figure 6.         ATF4 has a negative impact on the neuronal glutathione metabolism.   (A)  ATF4 +/+   (   ) and ATF4     /     (   ) cortical neurons were treated with 
10 mM HCA. At the indicated time points, cells were trypsinized, washed, and pelleted. Reduced glutathione (GSH) was determined in the cell pellets using HPLC 
electrochemical detection. Data are from three separate cultures, and each data point was measured in duplicate. Graph depicts mean   ±   SD. (B) Schematic 
overview over cysteine uptake and glutathione synthesis and their inhibition. (C) ATF4  +/+   and  ATF4    /     cortical neurons were treated with a vehicle control 
(shown as C) or 200   μ  M BSO. 24 h later, cell viability was determined using the MTT assay. The graph depicts mean (compared with control)   ±   SD calculated 
from fi  ve separate experiments for each group (  n   = 46 ATF4  +/+   and 58 ATF4     /    ). *, P   <   0.05 from untreated ATF4  +/+   cultures by the Kruskal-Wallis test followed 
by Dunn  ’  s multiple comparisons test. The difference between treated and untreated ATF4     /     neurons was not signifi  cant (n.s.). (D) Live/dead assay displaying 
untreated and BSO-treated ATF4  +/+   and  ATF4    /     neurons. Bar, 50   μ  m. (E) Protein expression of     -GCS does not differ between ATF4  +/+   and  ATF4    /     cortical JEM VOL. 205, May 12, 2008 
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pression reinstated sensitivity to oxidative death. We establish 
the relevance of protection by ATF4 defi  ciency by demon-
strating that the ATF4 homozygous knockout is capable of 
protecting the adult mouse brain from stroke-induced injury 
and disability. Indeed, we show that ATF4      /      animals recover 
more easily and maintain proper motor function more effi   -
ciently. Although known to be a stress-responsive protein, 
these results for the fi  rst time establish ATF4 as a redox-regu-
lated protein that can function to lower the threshold for oxi-
dative stress  –  induced death in neurons. 
  ATF4 is a redox-regulated transcription factor 
  Classically, stress-mediated enhancement of ATF4 levels is 
known to occur via enhanced effi   ciency of translation of 
constant levels of ATF4 mRNA (  29, 30  ). Consistent with 
this model, we found an up-regulation of ATF4 mRNA 
translational effi   ciency after glutathione depletion. How-
ever, we also observed an increase in ATF4 mRNA levels 
after oxidative stress, thereby confi  rming a recent report 
describing a role for transcriptional regulation in ATF4 in-
duction by cell stress (  31  ). The distinct increase in ATF4 
protein levels in the nucleus of neurons undergoing oxida-
tive stress corresponded to an ATF4-dependent induction 
of a TRB3 promoter-luciferase reporter. Collectively, these 
observations argue that oxidative stress  –  induced changes in 
ATF4 mRNA levels and translational effi   ciency lead to in-
creased ATF4 activity in neurons. Because ATF4 overex-
pression is suffi   cient to induce death, limiting the amount 
of ATF4, at least under basal conditions, seems to be neces-
sary for neuronal survival. Mechanisms that control and 
limit basal ATF4 activity (  32  –  34  ) appear to be important 
determinants of neuronal fate. Although this low level of 
ATF4 appears to be suffi   cient to regulate a host of genes, its 
absence does not grossly infl  uence neuronal morphology or 
basal survival. 
  ATF4 has a direct impact on glutathione metabolism 
  Several converging lines of inquiry demonstrate a central 
role for glutathione metabolism in degeneration and aging 
in the nervous system. Our fi  ndings confi  rm the primary 
role that glutathione can play in neuronal death. However, 
the mechanisms by which a global depletion of glutathione 
in neurons is transduced into apoptotic events remained 
elusive. The data presented in this study favor a model in 
the hippocampus. However, a signifi  cantly smaller infarct 
was observed when the procedure was performed in ATF4      /      
animals (  Fig. 7, C and D  ). The smaller infarct area could be 
observed in all sections of the brain. Thus, the higher resis-
tance to ischemia-reperfusion injury was not limited to a spe-
cifi   c brain area. In fact, the smaller infarct volume was 
associated with a faster recovery in ATF4      /      animals, as mea-
sured by a simple neurological score (  Fig. 7 E  ). In addition, 
two simple behavioral tests (  Fig. 7, F and G  ) complemented 
the morphological data. In consideration of the eye lens mal-
formation regularly observed in ATF4      /      animals (  25  ), these 
tests are not dependent on the visual sense. Consistent with 
the morphological data, ATF4      /      animals performed signifi  -
cantly better than the ATF4  +/+   control group, suggesting that 
ATF4 defi  ciency facilitates recovery after stroke. 
    DISCUSSION   
  ATF4 is a prodeath transcription factor 
  Solid evidence supports the hypothesis that oxidative stress is 
an initiator or propagator of neuronal dysfunction or death in 
prevalent neurological diseases, including stroke, spinal cord 
injury, Alzheimer  ’  s disease, and Parkinson  ’  s disease (  3, 27  ). 
These studies have led to the somewhat surprising conclusion 
that oxidants can trigger neuronal death via highly regulated 
signaling pathways and subsequent activation of prodeath tran-
scription factors, leading to the controlled demise known as 
apoptosis (  28  ). The current study adds to our understanding of 
the cellular transcription factors that regulate neuronal viability 
and function after oxidative stress in primary cortical neurons. 
Specifi  cally, we show that the transcription factor ATF4 is in-
duced by oxidative stress caused by depletion of the major an-
tioxidant tripeptide, glutathione. We further demonstrate that 
transgenic deletion of ATF4 renders neurons resistant to neu-
ronal cell death. Prevention of cell death by germline knock-
out of ATF4 is associated with a preservation of glutathione 
levels, the primary mediator of death in our oxidative stress 
model. Consistent with ATF4  ’  s role in regulating an early, 
upstream aspect of the oxidative neuronal death pathway, we 
found that ATF4 defi  ciency causes global down-regulation of 
gene expression and blocks the up-regulation of many genes 
that are induced by oxidative stress in WT neurons. Accord-
ingly, forced expression of ATF4 was suffi   cient to promote 
cell death and loss of glutathione. In addition, we demonstrate 
that in ATF4      /      neurons, restoration of ATF4 protein ex-
neurons. Cytoplasmic extracts were separated using gel electrophoresis and immunodetected using an antibody against     -GCS. Total eIF2     was  monitored 
as a loading control. (F) ATF4  +/+   (   ) and ATF4     /     (   ) cortical neurons were treated with 200   μ  M BSO. At the indicated time points, cells were trypsinized, 
washed, and pelleted. GSH was determined in the cell pellets using HPLC electrochemical detection. Data are from three separate cultures, and each data point 
was measured in duplicate. Graph depicts mean   ±   SD. (G) ATF4  +/+   cortical neurons were infected with GFP (    ), ATF4WT (    ), and ATF4   RK  (  )  adenoviruses 
at an MOI of 100. At the indicated time points after infection, cells were trypsinized, washed, and pelleted. GSH was determined in the cell pellets using HPLC 
electrochemical detection. The graph depicts mean   ±   SD calculated from three separate experiments for each group, and each data point was measured in 
duplicate. The value obtained from noninfected neurons was arbitrarily defi  ned as 100%. (H) ATF4  +/+   cortical neurons were infected with GFP and ATF4WT ad-
enoviruses at an MOI of 100. 24 h after infection, neurons were treated with vehicle control (shown as C), 10 mM HCA, 10   μ  M BHA, or a combination of both. 
The graph depicts mean (compared with control)   ±   SD calculated from fi  ve separate experiments for each group (  n   = 29). *, P   <   0.05 from untreated neurons 
overexpressing ATF4WT by the Kruskal-Wallis test followed by Dunn  ’  s multiple comparisons test. The difference between neurons overexpressing ATF4WT 
treated with BHA alone and neurons overexpressing ATF4WT treated with both BHA and HCA was not signifi  cant (n.s.). (I) Live/dead assay. Bar, 50   μ  m.    
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vation includes the increased production of ROS and turn-
over of glutathione. Although our data clearly establish that 
ATF4 induction does not infl  uence glutathione synthesis, 
we cannot determine whether the increased turnover of 
which glutathione depletion causes an ATF4-dependent 
up-regulation of a coordinated set of genes that orchestrate 
the timely and irreversible demise of the cell. Part of the 
orchestrated sequence of events downstream of ATF4 acti-
    Figure 7.         Role of ATF4 in brain ischemia.   (A, top) Sagittal sections of ATF4  +/+   (left) and ATF4     /     (right) brains stained with cresyl violet. Bar, 3,000   μ  m. 
(A, middle) Ventral view of large cerebral blood vessels of representative ATF4  +/+   (left) and ATF4     /     (right) mice that were perfused with India ink. 
Note the higher degree of tortuosity of the MCA in the brain from the ATF4     /     mouse. Bar, 3,000   μ  m. (A, bottom) Representative microscopic views of 
brain sections from ATF4  +/+   and  ATF4    /     mice that were immunostained for the endothelial cell  –  specifi  c marker CD31 (green). Bar, 100   μ  m. (B) Represen-
tative brain sections at 4 d after MCAo from ATF4  +/+   ( n   = 5) and ATF4     /     ( n   = 6) mice from rostral to caudal stained with cresyl violet to determine the 
infarct area. Bar, 1,000   μ  m. (C) The infarct area in ATF4  +/+   (   ) and ATF4     /     (   ) brains was measured in 12 sequential sections taken from ATF4  +/+   ( n   =  5) 
and ATF4     /     ( n   = 6) mice at rostral to caudal regular intervals. Graph depicts mean   ±   SD. (D) The infarct volume was assessed by adding the infarct vol-
umes based on the infarct area in each section. Graph depicts mean   ±   SD. *, P   <   0.0001 by the   t   test. (E) Scoring of neurological defi  cit was assessed at 
different time points of recovery in ATF4  +/+   ( n   = 5) and ATF4     /     ( n   = 4) mice. Graph depicts mean   ±   SD. *, P   <   0.05 by the Mann-Whitney test. (F) Inclined 
plane test at different time points after stroke in ATF4  +/+   ( n   = 5) and ATF4     /     ( n   = 4) mice. The test measured the time a mouse managed to hold itself on 
an inclined glass plate angled at 50  °   before sliding down. Graph depicts mean   ±   SD. *, P   <   0.05 by the   t   test. (G) Hanging wire test at different time points 
after stroke in ATF4  +/+   ( n   = 5) and ATF4     /     ( n   = 4) mice. The hanging wire test determined the time it took an animal to cross a distance of 45 cm on a 
freely hanging narrow metal bar. Graph depicts mean   ±   SD. *, P   <   0.05 by the   t   test.   JEM VOL. 205, May 12, 2008 
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addition to ATF4 induction (  2, 45  ). Which of these signaling 
events are capable of preventing the deleterious consequences 
of ATF4 activation requires further investigation. In general, 
the similarity of data obtained from fi  broblasts and from cor-
tical neurons is limited. However, despite the opposite eff  ects 
on glutathione metabolism and cell survival, a comparison 
between the array data from fi  broblasts with our gene ex-
pression data indicates a highly signifi   cant overlap. Even 
though the role of each of the many target genes of ATF4 
warrant further investigation, the diff   erent metabolic de-
mands of postmitotic neurons and actively dividing fi  bro-
blasts might help to explain the distinct role of ATF4 in 
distinct cell types (  46  ). Additionally, diff  erently expressed di-
merization partners of ATF4 might also signifi  cantly modify 
ATF4  ’  s function. Indeed, several diff  erent cancer cell lines 
show an elevated level of ATF4 expression (  10, 47  –  50  ). 
Moreover, ATF4 is already known to have functions that are 
limited to a specifi  c cell type such as osteoblasts (  40, 51, 52  ). 
The precise characterization of these additional signaling 
events warrants further investigation, and might help to ex-
plain why and how these signaling events are capable of pre-
venting the deleterious consequences of ATF4 induction. 
  ATF4 is a prodeath transcription factor in vivo 
  We have established that ATF4 also plays an important pro-
death role in an in vivo model of stroke. However, the use of 
conventional ATF4      /      animals poses a risk of bias on the 
outcome in a complex paradigm such as stroke (  53  ). There-
fore, the results need to be interpreted with caution. We can-
not rule out the possibility that ATF4 defi  ciency in all cell 
types of the brain and the body has an impact on stroke out-
come. However, no overt diff   erence was observed when 
comparing the brain morphology between WT and ATF4      /      
brains, including the vascular system. In addition, the smaller 
infarct size in the ATF4      /      mice could not be attributed to 
changes in systemic physiological parameters, including body 
temperature, or changes in cerebral blood fl  ow under basal 
conditions or after MCAo. However, an issue that was not 
addressed in this study is whether the ATF4      /      mice dis-
played an altered infl  ammatory response after ischemia that 
could explain the smaller infarct size. Although a higher pro-
pensity to infections or other immune-related alterations has 
not yet been observed in ATF4      /      mice, we cannot rule out 
the possibility that an altered infl  ammatory response (  54  ) is 
one reason for the smaller infarct volume in the ATF4      /      
mice. In summary, the strong correlation in the outcome be-
tween in vitro and in vivo studies lets us conclude that our 
results, even when reviewed carefully, suggest an important 
role for ATF4 in the induction of neuronal cell death. Thus, 
ATF4 might be an important target for therapeutic interven-
tion against stroke and other neurodegenerative diseases. 
  MATERIALS AND METHODS 
  Animals.     All animal procedures were performed according to protocols 
approved by the Institutional Animal Care and Use Committee of the Weill 
Medical College of Cornell University. Germline ATF4      /      mice have been 
described previously (  19  ). For the culture of mouse embryonic cortical 
glutathione is primarily attributable to a change in a gluta-
thione-degrading enzyme with a subsequent increase of ROS, 
or a secondary consequence of ATF4-mediated ROS pro-
duction. Increased ROS production would be expected to 
decrease glutathione levels by enzyme-mediated consump-
tion of the thiol tripeptide. Of note, many mitochondrial 
genes that could facilitate production of deleterious ROS 
during respiration are down-regulated in the ATF4      /      
neurons. Future studies will clarify whether ATF4 mediates 
death primarily by altering glutathione turnover or by dial-
ing up the production of free radicals. 
  ATF4 induces global transcriptional changes 
  ATF4 was originally described as a transcriptional repressor 
(  35, 36  ). However, our gene array data suggest that ATF4 
acts at least in part as a transcriptional activator. This fi  nding 
is in line with several more recent publications that describe 
the activating eff  ect of ATF4 on several target genes, such as 
heme oxygenase 1 (  37, 38  ), stanniocalcin 2 (  39  ), osteocalcin 
(  40  ), gadd153/CHOP (  41  ), and TRB3 (  42  ). Some of these 
target genes have been shown to play an important role in 
cell death and cell survival in the brain. Pharmacological in-
duction of heme oxygenase 1 was demonstrated to protect 
neurons from oxidative insults both in vitro and in vivo (  43  ). 
Indeed, heme oxygenase 1 is induced in WT neurons by oxi-
dative stress; however, it was down-regulated in ATF4      /      
neurons. Likewise, stanniocalcin 2 is up-regulated in response 
to oxidative stress in WT neurons but was down-regulated in 
ATF4      /      neurons. In a recent work (  39  ), stanniocalcin 2 was 
identifi  ed as an oxidative stress  –  responsive gene with cyto-
protective properties. A prodeath ATF4 target gene, TRB3, 
was strongly dependent on ATF4 and up-regulated in re-
sponse to oxidative stress. TRB3  ’  s role in neuronal apoptosis 
was described fi  rst in a neuronal cell line (  44  ) and has been 
recently confi  rmed (  42  ). 
  The prodeath role of ATF4 might be context 
and cell type specifi  c 
  The data presented in this work are in support of a strong 
prodeath role of ATF4. However, previous fi  ndings regard-
ing the roles of ATF4 have yielded partly diff  erent results. 
ATF4      /      fi   broblasts are impaired in expressing genes in-
volved in amino acid import, glutathione biosynthesis, and 
resistance to oxidative stress (  11  ). Therefore, ATF4 was pro-
posed to play a key role in rendering the cell more resistant 
against the metabolic consequences of endoplasmic reticulum 
oxidation. Therefore, we initially hypothesized that ATF4 
induction by endoplasmic reticulum stress or amino acid de-
pletion is the key event in the protection against oxidative 
stress mediated by HCA treatment (  Fig. 1  ). The fi  nding that 
ATF4 activation can be associated with protection from oxi-
dative stress  –  induced cell death, although it clearly acts as a 
prodeath transcription factor, points to a complex and con-
text-specifi  c role of ATF4 in the propagation of neuronal cell 
death. However, both endoplasmic reticulum stress or amino 
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http://www.bioconductor.org; reference   57  ). Raw data were log2 trans-
formed and normalized using quantile normalization. Analysis of diff  erential 
expression was performed using a linear model fi  tting (LIMMA package; ref-
erence   58  ). The obtained p-values were corrected for multiple testing using 
the false discovery rate method, and a threshold of 0.05 was applied. Micro-
array data have been deposited in the National Center for Biotechnology 
Information Gene Expression Omnibus under accession no.   GSE10470  . 
  DNA EMSA.     Crude nuclear extracts were purifi  ed by dialysis using Slide-
A-Lyzer MINI Dialysis Units (Thermo Fisher Scientifi  c). The following 
oligonucleotide probes (Invitrogen) corresponding to the ATF4 binding site 
of the TRB3 gene were used: TRB3WT, 5    -GATTAGCTCAGGTTTA-
CATCAGCCGGGCGGGGA-3    ; and TRB3MUT, 5    -GATTAGCT-
CAGTCTAAACCTATAGGGGCGGGGA-3    . The oligonucleotides were 
annealed with complementary DNA and radiolabeled with     -[  32  P]ATP us-
ing T4 polynucleotide kinase. After incubation with nuclear extracts, the 
DNA  –  protein complexes were resolved in 5% polyacrylamide gels, and the 
signal was visualized using a PhosphorImager (Fujifi  lm). 
  Chromatin immunoprecipitation assay and PCR amplifi  ca-
tion.     Formaldehyde cross-linking and chromatin immunoprecipitation 
were performed as described previously (  59  ). The cross-linked chromatin 
suspension was sonicated using a Sonicator 3000 (Mosonix). Immuno-
precipitation was performed with an anti-myc antibody. DNA  –  protein 
cross-linking was reversed, followed by an overnight incubation at 65  °  C. 
DNA was isolated by phenol/chloroform extraction and subjected to PCR 
analysis using the primers 5    -GGTCACAGATGGTGCAATCC-3     and 
5    -AACTGAGCAGCTCTCGGAGTC-3    . 
  Glutathione determination using HPLC electrochemical detection 
and ROS detection using DCF fl  uorescence.     Concentrations of reduced 
glutathione were measured using HPLC (PerkinElmer) equipped with an 
eight-channel coulometric array detector (ESA, Inc.). Cells were lysed in 5% 
(wt/vol) metaphosphoric acid and centrifuged at 10,000   g   for 10 min to sedi-
ment protein. Cell-pellet precipitates were saved for protein determinations. 
Glutathione concentrations of supernatant fractions were determined by in-
jecting 5-  μ  l aliquots onto an Ultrasphere 5 u, 4.6   ×   250 mm, C18 column 
(Beckman Coulter), and eluting with a mobile phase of 50 mM NaH  2  PO  4  , 
0.05 mM octane sulfonic acid, 1.5% acetonitrile (pH 2.62) at a fl  ow rate of 
1 ml/min. Peak areas were analyzed using software from ESA, Inc. Intracellular 
generation of ROS was determined by DCF. Cortical neurons were seeded in 
96-well fl  uorescence plates. After the treatments indicated in the fi  gures, the 
cultures were incubated for 45 min with 1.25   μ  M DCF-H  2  . Cells were washed 
with HBSS and read on a plate reader (Fluorometer; MDS Analytical Tech-
nologies) at 485-nm excitation and 530-nm emission wavelengths. 
  Cerebral ischemia.     Transient focal cerebral ischemia was induced by 
MCAo using the intraluminal fi  lament method, as previously described (  23  ). 
Male mice were anesthetized. A small incision was performed in the skin 
covering the scalp, and a fi  ber optic probe was glued to the parietal bone and 
connected to a laser-Doppler fl  owmeter (Perifl  ux System 5010; Perimed) for 
continuous monitoring of cerebral blood fl  ow. For MCAo, a heat-blunted 
black monofi  lament surgical suture (6-0) was inserted into the exposed ex-
ternal carotid artery, advanced into the internal carotid artery, and wedged 
into the circle of Willis to obstruct the origin of the MCA. The fi  lament was 
left in place for 45 min and withdrawn. 
  Physiological parameters.     Animal physiology was assessed in ATF4  +/+   
and ATF4      /      mice (  n   = 3 each). For this purpose, the left femoral artery was 
cannulated using a polyethylene tube (PE-10; BD Biosciences) to record 
mean arterial blood pressure. Blood samples were taken for chemical analysis 
using a hand-held blood analyzer (iSTAT; Abbot Laboratories). 
  Quantifi  cation of infarct volume.     Coronal brain sections were serially 
cut in a cryostat (Leica) and stained with cresyl violet to identify viable tissue. 
neurons, embryos (15.5 days post conceptionem) were obtained from the 
mating of ATF4 heterozygous mice. 
  Primary cortical neurons and cell culture.     Primary neuronal cultures 
were prepared from the cerebral cortices of mouse embryos, as described 
previously (  55  ), with minor modifi  cations. The mouse hippocampal cell line 
HT22 was maintained according to standard procedures (  56  ). Transfection of 
both cortical neurons and HT22 cells was performed using Lipofectamine 
2000 (Invitrogen) according to the manufacturer  ’  s instructions. Recombinant 
arginase was provided by D. Ash (Temple University, Philadelphia, PA). 
  Genotyping.     Genomic DNA for PCR was prepared using the DNeasy 
genomic DNA isolation kit (QIAGEN). The WT alleles were detected us-
ing the primer 5   -AGCAAAACAAGACAGCAGCCACTA-3    . The ATF4      /      
alleles (neomycin) were detected using the primer 5    -ATATTGCTG-
A  A  G  A  G  CTTGGCGGC-3    . As a common reverse primer, we used 
5    -  G  T  T  T  C  T  A  CAGCTTCCTCCTCCACTCTT  -3    . 
  Cell viability/cell death assays.     Cell viability was assessed by propidium 
iodide uptake and retention of calcein (Invitrogen) using an inverted epi-
fl  uorescence microscope (Axiovert 200M; Carl Zeiss, Inc.). MTT assay was 
performed according to the manufacturer  ’  s instructions (Promega). In brief, 
absorbance was measured at 570 nm. From each data point, the reference 
absorbance measured at 690 nm was subtracted. Finally, values were calcu-
lated as the percentage of untreated control cells. 
  Plasmids.     The expression plasmids for ATF4WT and dominant-negative 
ATF4    RK (provided by J. Alam, Ochsner Foundation, New Orleans, LA) 
(  37  ), and the mouse ATF4 5    UTR luciferase construct (D. Ron, New York 
University, New York, NY) have been previously described. The promoter 
construct pTRB3 was generated by amplifi  cation of genomic mouse DNA 
using the primers 5    -CTCACTCAGGTGCCTGTAGTGCTCG-3     and 5    -
TCAGCAGAAGCAGCCAGAGGTGTAG-3    , followed by a second round 
of PCR with the primers 5    -ACACTCGAGAGAGAAACAAATGTGT-
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